Small-size drug-eluting beads TACE for the treatment of hepatocellular carcinoma:its safety and efficacy analysis

VernacularTitle:小粒径载药微球在肝细胞癌治疗中的安全性和疗效分析
Author: Saifeng ZHANG ¹ ; Daoren WANG ; Guoliang SHAO
Author Information

1. 310053 浙江杭州天台县人民医院(浙江省人民医院天台分院)放射科;浙江中医药大学研究生院
Keywords: hepatocellular carcinoma; drug-eluting bead; transcatheter arterial chemoembolization
From: Journal of Interventional Radiology 2024;33(12):1373-1377
CountryChina
Language:Chinese
Abstract: Hepatocellular carcinoma(HCC)is one of the most common malignant tumors worldwide.Transarterial chemoembolization(TACE)has been an important method for the treatment of advanced HCC.At present,drug-eluting beads chemoembolization(DEB-TACE)has been widely employed in the treatment of HCC,and different brands and different sized drug-eluting beads have been developed and used in DEB-TACE.In clinical practice,the particle size of drug-eluting beads is selected according to the HCC size and its blood supply,generally,＜300 μm drug-eluting beads are recommended.At present,100-300 μm drug-eluting beads have been frequently used.In recent years,smaller-sized drug-eluting beads have been employed in TACE.This article reviews the clinical effectiveness and safety of small-sized drug-eluting beads(＜150 μm)in DEB-TACE for HCC,so as to provide reference for clinical treatment.